Schedule 13D ownership disclosure
Arcutis Biotherapeutics Inc
Security class unavailable · CUSIP: 03969K108
Event date: 2022-08-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-214960
- Form type
- SC 13D
- Filer
- Arcutis Biotherapeutics, Inc.
- CIK
- CIK 1787306
- Filed
- Aug 08, 2022
- Reporting period
- Aug 05, 2022
- Description
- Schedule 13D beneficial ownership